Skip to content

Clinical trials

Phase 2 Liver Cirrhosis trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Cirrhosis Phase: Phase 2 Country / region: France Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20043
20122
20151
20171
20181
20191
20223
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated6
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi3
AstraZeneca2
Gilead Sciences2
Boehringer Ingelheim1
Celgene1
European Foundation for Study of Chronic Liver Failure1
Galmed Research and Development, Ltd.1
Hepion Pharmaceuticals, Inc.1
Novartis Pharmaceuticals1
Tobira Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Cirrhosis14
Non-alcoholic Fatty Liver Disease8
Ascites3
Fatty Liver2
Fibrosis2
Liver Diseases2
Acute-On-Chronic Liver Failure1
Diabetes Mellitus1
Hypertension, Portal1
Hyponatremia1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.